M&T Bank Corp Grows Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

M&T Bank Corp grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,784 shares of the real estate investment trust’s stock after purchasing an additional 367 shares during the quarter. M&T Bank Corp’s holdings in Omega Healthcare Investors were worth $1,212,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. State Street Corp increased its holdings in Omega Healthcare Investors by 0.9% during the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock worth $502,228,000 after purchasing an additional 114,085 shares during the period. FMR LLC grew its position in shares of Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares in the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after buying an additional 3,003,845 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Omega Healthcare Investors by 6.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock valued at $155,893,000 after acquiring an additional 240,006 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after acquiring an additional 272,299 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on OHI shares. Truist Financial raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Mizuho increased their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a research report on Thursday, December 5th. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $40.18.

Omega Healthcare Investors Price Performance

Shares of OHI stock opened at $39.21 on Monday. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The firm has a market capitalization of $10.58 billion, a price-to-earnings ratio of 28.83, a PEG ratio of 1.21 and a beta of 0.98. The stock’s 50-day simple moving average is $40.38 and its 200-day simple moving average is $37.97.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. Omega Healthcare Investors’s payout ratio is 197.06%.

Insiders Place Their Bets

In related news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.